AwesomeCapital
Search This Blog
Saturday, April 6, 2019
Amgen (AMGN) Could See $13 Benefit From NVS Breach – RBC
RBC Capital analyst Kennen MacKay reiterated a Sector Perform rating on Amgen (NASDAQ: AMGN) and sees potential for +$10-$13/share.
https://www.streetinsider.com/Analyst+Comments/Amgen+%28AMGN%29+Could+See+%2413+Benefit+From+NVS+Breach+-+RBC/15344184.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.